Lead Product(s) : Staphylococcus Epidermidis Strain
Therapeutic Area : Dermatology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Based on the results of the research partnership, Bayer plans to develop selected Staphylococcus epidermidis strains into new natural skin care products under a future License Agreement.
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
October 01, 2020
Lead Product(s) : Staphylococcus Epidermidis Strain
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable